PART 2U.K.Pharmaceutical needs assessments

Temporary extension of [F1earlier] pharmaceutical needs assessments and access by [F2NHS England] and HWBs to pharmaceutical needs assessmentsU.K.

7.—F3(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

[F4(1A) Prior to the publication by a HWB (“HWB1”) of the first pharmaceutical needs assessment that it prepares for its area, as required by regulation 6(A1) or (A3), the pharmaceutical needs assessment that relates to any locality within its area is the pharmaceutical needs assessment of the HWB (“HWB2”) for that locality prior to the establishment of HWB1, read with—

(a)any supplementary statement relating to that assessment published by HWB2 under regulation 6(3) (which has become part of that assessment); and

(b)any supplementary statement relating to that assessment published by HWB1 under regulation 6(3A).]

(2) Each HWB must ensure that [F2NHS England] has access to—

(a)the HWB's pharmaceutical needs assessment (including any supplementary statement that it publishes, in accordance with regulation 6(3), that becomes part of that assessment);

(b)any supplementary statement that the HWB publishes, in accordance with regulation [F56(3A), in relation to another HWB’s] pharmaceutical needs assessment; and

(c)any pharmaceutical needs assessment of a Primary Care Trust that it holds,

which is sufficient to enable [F2NHS England] to carry out its functions under these Regulations.

(3) Each HWB must ensure that, as necessary, other HWBs have access to any pharmaceutical needs assessment of a Primary Care Trust that it holds, which is sufficient to enable the other HWBs to carry out their functions under these Regulations.

Textual Amendments